People with Diabetes Archives

The diabetes industry won’t just evolve in 2026. It will continue to undergo a fundamental shift in how care is defined, delivered, and experienced. What was once a landscape dominated by manual tracking and reactive treatments has transformed into a proactive, connected, data-driven ecosystem of diabetes devices, management platforms, manufacturers, digital therapeutics, consumables, educators, and drug therapies.

In 2026, the focus is no longer just about managing diabetes, but about mastering it through integrated data, connected devices and apps, and AI-enabled insights. Glooko’s core mission has always been to bridge the gap between people living with diabetes and healthcare providers through clear, actionable data. This year, we are strengthening that connection by offering innovative solutions like EndoTool, developed by Monarch Medical Technologies, a Glooko Company, and Glooko. Together, these technologies can bridge the continuum of care from inpatient glycemic management to outpatient diabetes management.

To better understand where the industry is going, we asked our experts for their insights and predictions for 2026.

Advancing Diabetes and Glycemic Management in 2026

“The diabetes landscape is set for a massive transformation in 2026. With the launch of the CMS ACCESS Model, we are shifting from simply tracking data to rewarding positive health outcomes during hospital stays. However, as a wave of new CGMs, AI-enabled health software and wearables, and smart pens hits the market, these technologies can quickly overwhelm outpatient care teams. Trusted digital health solutions that bridge these settings, unifying disparate devices into one clear, actionable clinical picture using data, will be key.

This move toward data liquidity means vital information is no longer trapped in a single device or clinical encounter. By integrating inpatient systems with outpatient platforms, care can be more proactive and continuous, especially as new federal quality measures for glycemic safety take full effect this year. We aren’t just looking at numbers anymore; we need to use intelligent, AI-powered insights to make the daily burden of diabetes feel lighter. We’re moving beyond ‘tech for tech’s sake’ and toward a simpler, more connected reality that puts the person before the data.”

– Mike Alvarez, CEO, Glooko

The Rise of New Digital Health Standards and Connected Care

“In 2026, the strategic focus for health systems will shift from fragmented point solutions to a unified continuum of care. As hospitals face tightening margins and new outcome-based payment models like CMS ACCESS, they’ll seek integrated platforms that standardize management for chronic conditions like diabetes across both inpatient and outpatient settings. By consolidating disparate tools into a single, EHR-integrated ecosystem, systems can reduce the cost of maintaining multiple interfaces.

Remote patient monitoring will also see new life in 2026. New programs like the federal Rural Health Transformation Program are bridging the “digital divide” and refocusing on the benefits of connected, digital-forward care. This $50 billion funding allows underserved, rural clinics to adopt advanced AI and remote monitoring tools that were previously limited to urban centers, enabling evidence-based chronic condition management closer to home. By leveraging grants to modernize interoperability and cybersecurity, rural healthcare providers ensure that high-quality, connected diabetes care is no longer determined by a patient’s zip code, but is instead the universal standard.”

– Rich Glenn, President, Connected Care, Glooko

Evolving from Siloed Data Collection to Integrations and Precision Engagement

“This year, we will keep expanding our current support of episodic care to include continuous care, evolving beyond our expertise in data collection to the design of digital ecosystems that bridge the gap between people with diabetes, their device data, and healthcare providers. This shift will replace fragmented data silos with a unified infrastructure where information from diabetes devices and health monitoring apps flow seamlessly into clinicians’ primary workflows via EHR integrations. We must ensure that continuous data isn’t an overwhelming burden, but an enabling and actionable asset. This collaborative framework alleviates burnout by giving the entire care team an on-demand ‘single source of truth,’ allowing care teams to intervene proactively and spend less time navigating software and more time practicing at the tops of their licenses.

Given recent FDA guidance on wellness wearables and clinical decision support software, we may now be entering a new era of precision engagement fueled by AI. With the latest generations of CGM devices and automated insulin delivery (AID) systems, the field has already moved beyond just seeing data to predicting outcomes and using AI to forecast hypoglycemic events with immediate, context-rich alerts to the person with diabetes. This automation allows patients to manage their care more independently than ever before. However, people with diabetes still benefit from expert teams that can co-pilot their care. There will always be a vital need for care teams to step in when clinical complexity arises or the individual is not achieving their diabetes management goals.”

– Mark Clements, MD, PhD, Chief Medical and Strategy Officer, Glooko

Making Glycemic Safety a Mandatory Protocol

“In 2026, inpatient glycemic safety will transition from a clinical preference to a mandatory system requirement. With CMS now linking reimbursement and quality ratings to the reporting of severe glycemic events, hospitals can no longer rely on the manual vigilance of individual clinicians to manage insulin therapy. Success now requires moving away from fragmented “sliding scale” protocols and toward purpose-built platforms like EndoTool that ensure consistent, evidence-based dosing and the ability to track outcomes in real time. By treating glycemic management as core safety infrastructure, hospitals and health systems can reduce costly variability, meet new regulatory demands, and allow clinicians to focus on patient care rather than manual calculations.”

– Paul Chidester, MD, Medical Director, Glooko

View Dr. Chidester’s full 2026 outlook on glycemic safety

Solving Specialist Shortages and Clinician Burnout Through Integrated AI and Enhanced Patient Literacy

“Clinician burnout will remain a top priority in 2026, driven in part by the mental exhaustion of managing disjointed tools outside the EHR. This year marks a turning point: embedding integrated data and interoperability within existing workflows will automate administrative tasks, streamline documentation, and provide unified patient views for better clinical decisions. The result will likely be improved provider capacity, proactive care delivery, and sustainable models that optimize both clinical and operational outcomes.

As the endocrinologist shortage intensifies, primary care teams will increasingly leverage specialized healthcare AI tools, including ChatGPT for Healthcare, to reduce administrative burden and enable top-of-scope care delivery, effectively increasing capacity without adding staff.

We will continue to be immersed in the era of the AI-empowered patient. Patients already use tools like ChatGPT Health to synthesize their data, including glucose trends and lab results, before appointments. This increasing health literacy will continue to transform basic data reviews into high-value, collaborative discussions where both clinicians and patients leverage AI for more informed decision-making.”

– Trisha Martinez, BSN, MBA, RN, Senior Director, Clinical Transformation, Glooko

Securing the Digital Health Ecosystem to Thwart AI-Driven Cyberattacks

“In 2026, healthcare data privacy and cybersecurity will undergo a fundamental shift as cyber threats transition to AI-driven, autonomous models. Healthcare organizations must pivot toward ‘agentic resilience,’ a proactive approach leveraging agentic AI, autonomous systems capable of making decisions and executing tasks. These agents can address the vulnerabilities inherent in connected medical ecosystems, such as the possible cyberattack risks present in clinical workflows and medical devices, including connected insulin pumps and CGMs.

To mitigate security risks in 2026, healthcare organizations should also transition toward a robust security framework that replaces traditional passwords with identity-based access control and advanced authentication methods, such as biometric passkeys and MFA. By implementing universal verification, every access request can be rigorously validated regardless of its source, ensuring the integrity of clinical workflows and protecting sensitive health data from unauthorized entry.”

– Ben Chang, Vice President, Security and IT Operations, Glooko

Entering a Highly-Competitive, Integration-First Diabetes Device Ecosystem

“We’re entering the year in a global diabetes landscape that has matured into a competitive, integration-first ecosystem that demands collaboration. With the global diabetes device market projected to exceed $37.9 billion, we are seeing an influx of regional manufacturers offering new device alternatives, giving healthcare providers and people with diabetes a wider array of care choices. This diversification is further accelerated by the mainstream adoption of tubeless patch pumps, CGMs, and non-invasive wearable technologies tailored for the Type 2 diabetes and wellness segments.

From a partnership perspective, these trends reinforce a vital market truth that hardware is no longer a standalone solution. As the number of devices expands, the ultimate competitive advantage belongs to those who prioritize interoperability, integrating effortlessly into the patient’s life and the clinician’s EHR system.”

– Dave Conn, Executive Vice President, Global Alliances, Glooko

Furthering Connected Diabetes Care in Europe

“We’ll continue to move away from disconnected diabetes devices and toward integrated digital ecosystems. As connected care becomes the standard for delivering value, diabetes management will increasingly rely on a coordinated combination of medication, smart hardware, and artificial intelligence, all operating under the supervision of healthcare professionals through structured remote monitoring.

For remote monitoring to be effectively adopted, it must be embedded within national and regulatory frameworks defined by local health authorities. Strict alignment with evolving EU regulations on AI and health data will also remain a central priority.

In terms of devices, the evolution of algorithm-driven AID systems into sophisticated ‘digital companions’ will be the catalyst for a broader diabetes management transformation. By combining predictive AI with remote monitoring, healthcare providers can anticipate patient needs and manage populations remotely, offering a scalable solution to Europe’s workforce challenges by effectively shifting care from hospital settings into the home.”

– Alex Evans, Vice President, Connected Care, EMEA, Glooko

Smarter Technology to Empower People Living with Diabetes

“Over the past few years, managing my diabetes finally felt less like a full-time job and more like a background app running on my phone. We’ve moved away from the constant stress of finger sticks and manual math thanks to the latest AID systems and high-tech sensors that talk to each other better than ever before. These smart systems do the heavy lifting for many, catching highs and lows before they even happen, which takes a huge weight off the shoulders of people with diabetes. Even for those of us who don’t use a pump, connected smart pens can now automatically log every dose, so there’s a lot less guessing and worrying. In 2026, I think we’ll see even more technology that helps to further reduce burnout, keep costs more manageable, and help people stay in range, while thinking about diabetes a little less.”

– Hadley Horton, Senior Partner Manager, Glooko

Ready to prepare your hospital, health system, or clinic for the rest of 2026?

Contact our team for a demo of our outpatient Glooko diabetes management platform and inpatient EndoTool Glucose Management System.

EndoTool is developed and marketed by Monarch Medical Technologies, a Glooko Company. EndoTool is an FDA-cleared Class II medical device indicated for inpatient use as described in its Instructions for Use. Glooko’s diabetes management platform and EndoTool are currently independent solutions.

We’re excited to share the latest updates included in Glooko Web 25.4 and Glooko Mobile 6.14, which are designed to help healthcare providers and care teams move faster with easier-to-understand risk insights, while also making it easier for people living with diabetes to connect devices and apps and remotely share data with their care teams.

Enhancements to the Glooko Clinic Dashboard

The Glooko clinic dashboard, designed to improve diabetes population health management and available in select countries, now features enhanced usability and accuracy improvements, making risk insights clearer for faster action across clinics, hospitals, and health systems.

Other enhancements to our population health tool include:

Clearer risk visibility: An updated Time in Range layout makes low and very low glucose risk easier to identify at a glance.
Smarter patient ranking: Patients with diabetes are prioritized by risk category, then by severity of the triggering metric.
More precise metrics: Risk indicators are displayed with greater precision for clearer comparison and trend tracking.

More Efficient Patient Review in the Glooko Web App

The patient list in the Glooko Web App for healthcare providers has been enhanced to support faster, more efficient workflows and smoother navigation.

Care teams can now see more patient data at once with a wider default view that reduces horizontal scrolling, sort patients better with improved cues that make patient order easier to understand, and see key context through a revised header that stays visible as they scroll through the list.

Streamlined Clinical Workflows with Full Glooko Access in Epic

Healthcare providers using Patient Portal for Professionals can now access the full Glooko Web App directly within the Epic EHR system using SSO via SMaRT on FHIR, reducing platform switching and streamlining daily workflows.

Some of the benefits of this helpful enhancement include launching our diabetes management platform without leaving the EHR or logging in again, the use of core features including the clinic dashboard, patient list, and device assignment within Epic, faster review and action using key patient diabetes data, and reduced clinician burnout from not context switching.

If your clinic is interested in this feature, please email [email protected].

Simplified Device and App Management for People with Diabetes

Managing diabetes and health monitoring devices and apps is now quicker and intuitive in the Glooko Mobile App.

Our newly enhanced search and smarter filtering, better device categorization, and refreshed visuals, including logos, make it easier for people with diabetes to find and connect their devices and apps with fewer clicks. The update also features shortcuts to speed up Glooko’s seamless integration with more than 200 compatible diabetes and health monitoring devices and apps. Once connected, patient data can be securely shared remotely with care teams who can make more informed treatment decisions.

More Information on the Latest Glooko Release

To learn more about these updates, check out the full release notes on our Support Center or reach out to your dedicated Glooko Customer Success Manager.

As 2025 comes to a close, it is clear that this has been a defining year for Glooko and for the broader evolution of diabetes care. Following the close of our Series F, we entered the year with a clear focus: deliver on our strategy, expand our global impact, and continue building technology that helps make diabetes care more connected, actionable, and human.

Accelerating our Mission through Strategic Leadership and a Connected Care Continuum

Over the past year, we reached several important milestones in support of that goal. We expanded our capabilities through the acquisition of Monarch Medical Technologies and its EndoTool Glucose Management System, bringing together complementary capabilities across outpatient and inpatient diabetes and glycemic management.

We strengthened our ecosystem with the launch of our Abbott FreeStyle Libre integration in the U.S., helping ensure that critical glucose data can flow more seamlessly to people with diabetes and their care teams.

We also reinforced our clinical leadership with the appointment of Mark Clements, M.D., Ph.D., as Chief Medical and Strategy Officer, underscoring our commitment to evidence-based innovation and strong clinical partnership.

Driving Digital Health Adoption in EMEA

We also saw meaningful traction across geographies and care settings.

In EMEA, we continued to expand our presence as health systems look for scalable, interoperable digital solutions to support diabetes care. At the same time, Glooko XT, our remote monitoring solution available only in France, introduced new features and strengthened its gestational diabetes management capability, an area where timely insights and coordinated care are critical for both maternal and fetal outcomes. These areas of momentum reflect the growing demand for digital tools that can support diverse patient populations and clinical workflows.

Further Enhancing our Diabetes Management Platform to Improve Care

On the product front, we continued to invest in tools designed for the realities of care delivery.

The launch of the new Glooko clinic dashboard marked an important step forward in helping clinics and health systems move beyond raw data to clearer insights, enabling more informed, timely decisions at the point of care. Across the organization, we remained focused on bringing teams together around a shared mission and shared standards, ensuring that our growth continues to be purposeful and aligned.

A reality faced by care teams each day is the need for timely, actionable data within existing clinical workflows. That’s why we invested further into our EHR capabilities this year and joined the Epic Showroom to make it easier for hospitals and health systems to seamlessly integrate their EHR with Glooko, helping reduce clinician burnout and optimize clinical workflows.

The Glooko Mobile App for people with diabetes also continued to innovate in 2025 with a redesigned food tracker for more insightful nutrition data and insights, revised insulin cards for more clarity, and viewable GLP-1 doses. These enhancements enable care teams to make more informed and timely treatment decisions between appointments using their patients’ health data – all viewable in one place.

How the U.S. Healthcare System is Moving Toward Data-Driven, Accountable Diabetes Care

These milestones matter, but they are occurring against a broader backdrop of change in healthcare that strongly validates this direction. The latest American Diabetes Association’s Standards of Care reinforce what clinicians and people with diabetes have long understood: technology-enabled management and data-driven insights are now foundational to delivering high-quality diabetes care.

At the same time, policy initiatives such as the CMS ACCESS program signal a growing emphasis on interoperability, data liquidity, and the responsible use of health data to improve outcomes at scale.

Together, these shifts point to a future in which diabetes care is increasingly proactive rather than reactive, and where data is not simply collected, but translated into meaningful action.

Regulatory momentum is reinforcing the importance of consistent, evidence-based glycemic management across care settings. CMS’s upcoming electronic clinical quality measure (eCQM) requirements for inpatient glycemic management, expected to take effect in 2026, reflect a growing emphasis on standardization, measurement, and accountability in hospital-based diabetes care. Solutions like EndoTool are at the forefront of this shift, helping health systems operationalize best practices, support clinical decision-making, and drive more reliable glycemic outcomes at scale.

For healthcare providers and care teams, this evolution brings both opportunity and urgency. As care becomes more continuous and data-rich, success depends on having tools, like Glooko’s EHR integrations, that reduce complexity, surface what matters most, and fit naturally into clinical workflows. The goal is not more data for its own sake, but clearer insight that supports better decisions and more personalized care.

For health systems, the focus is expanding to population-level impact. Managing chronic disease across diverse populations requires platforms that enable earlier intervention, more consistent care, and coordination across settings. Interoperable digital solutions, like Glooko, are becoming essential infrastructure for balancing quality, efficiency, and cost in an increasingly complex care environment.

Leveraging Scalable Healthcare Technology to Deliver Consistent Diabetes Care Around the World

Globally, the stakes are even higher. Diabetes prevalence continues to rise across regions with very different healthcare resources and delivery models. Scalable digital health solutions offer a path to extend evidence-based care, support clinicians, and bring greater consistency to diabetes management worldwide. As global standards and policies evolve, technology will play a central role in enabling more equitable access to high-quality care.

The Road Ahead for Glooko

Looking ahead, our focus at Glooko remains clear. We will continue investing in platforms that turn diabetes data into insight, insight into action, and action into better outcomes. We will deepen partnerships across the ecosystem and stay closely aligned with clinicians, health systems, and people with diabetes as their needs continue to evolve.

2025 was a year of momentum for Glooko. More importantly, it reinforced why our mission matters. As the future of diabetes care continues to take shape, we are energized by the opportunity to help lead the way.

Through our ongoing commitment to enhancing diabetes care and simplifying diabetes management, we launched a redesigned food tracking experience in the Glooko Mobile App, making logging faster, more flexible, and even more insightful.

This powerful upgrade, featured in the Glooko Web App 25.3 and Mobile 6.13 release, is designed with the core purpose of making it easier for people with diabetes to log meals and for clinicians, endocrinologists, and the entire care team to streamline reviewing nutrition data alongside glucose trends, insulin doses, and exercise.

The new interface transforms the meal logging process, ensuring people with Type 1 diabetes, Type 2 diabetes, gestational diabetes, and prediabetes are more engaged with their nutrition tracking than ever before. For clinicians, the tool delivers the rich, contextual data needed for more impactful appointments and timely, data-backed interventions.

Ways for Easier and More Flexible Food Logging

The goal of the redesign was simple: make tracking food as quick and intuitive as possible for Glooko Mobile App users with diabetes. The new mobile experience allows users to:

Log Meals by Type: Start by simply selecting a meal type (breakfast, lunch, dinner, or snack).
Multiple Input Methods: Add food items instantly through a variety of convenient methods:
- Manual search of our expansive database of food items (Select languages only)
- Barcode scanning (U.S. only)
- Voice input (Select languages only)
- Quick add from our food database or through custom entry
Customize and Save Favorites: App users can now create custom food entries and easily mark meals or food items as favorites with a single tap of a heart for lightning-fast logging next time.
Review Before Saving: The ability to edit existing items for time, data, and serving size, or review the full meal with detailed nutritional summaries ensures accuracy before the data is saved.
View the Summary: A nutritional summary now appears after each logged meal to help users better understand their daily intake.

Providing Smarter Nutrition Insights and Visualizations

The new design goes beyond logging to provide users with a clearer picture of their diet composition:

Track Macro Distribution: The Glooko Mobile App now tracks the distribution of carbs, fat, and protein as a percentage of total calories per day. This vital feature helps users quickly assess if macro intake aligns with dietary goals and how it may be influencing glucose patterns.
Data-Packed Charts and Graphs: The simplified logging process means more consistent data, which is viewable in the Daily Log and a new Food Graph below the Carbs section of Charts and Graphs, allowing users to better understand diet-related glucose fluctuations and discuss potential changes with their care teams.
Enhanced Meal Visualization: Users and care teams can now view added meals directly in the History List of the Glooko web app, with each entry displaying the exact meal type, nutritional information, and details of the included food. This enhanced visualization provides a better understanding of how nutrition works together with insulin doses, exercise, medications, and weight. Previous views of carbs are still available in the Overview Graph, Daily Graph, Weekview, and Calendar.

A Comprehensive Approach to Diabetes Management

This revamped food tracking experience is more than just an update — it’s a powerful tool designed to foster better patient engagement and deliver insightful data people with diabetes and their healthcare providers need to manage diabetes more effectively.

With nutrition, exercise, medication, lifestyle management, and other health data, we’re creating a better way to manage diabetes. To get started, download the Glooko Mobile App on the App Store and the Google Play Store today.

*Not all product features are available in all countries.

Whether training for a marathon or curious about blood sugar trends when out on a neighborhood walk, tracking and uploading fitness and health data is easy with the Glooko Mobile App for people living with diabetes.

Bringing together exercise, health, and diabetes data from compatible diabetes and health monitoring devices and apps with Glooko enhances diabetes management and allows people with diabetes and their healthcare provider to have greater insight about what adjustments might need to be made in care plans. Having the data available in one place makes it easier for care teams to make more informed decisions about treatment moving forward.

As an added benefit, next time people living with diabetes won’t have to guess when their care team asks how many minutes of exercise they did in a week.

Glooko’s Compatibility with Health Monitoring and Fitness Devices and Apps

Our connected care platform is compatible with leading health monitoring and fitness devices and apps like Apple Health, activity trackers and smartwatches from Fitbit, Strava, Garmin, and blood pressure cuffs and scales from Withings. For select diabetes devices, Glooko can share glucose, CGM, and manually entered insulin data in Glooko with Apple Health. Glooko Mobile App users also have the ability to manually track physical activity by selecting a variety of sports and exercises built into the platform and note the duration, calories burned, and intensity (light, medium, and hard).

When coupling these apps and manual entry of exercise history with the glucose, insulin, and the nutrition tracking capabilities of Glooko, the physical activity data provides care teams the ability to craft more personalized treatment plans and to see how different activities affect levels.

Once this helpful exercise data is imported into Glooko through a sync or manually,it can be found in a variety of our Glooko platforms, including Summary, Graphs, and History, depending on the data. This section provides key information such as step count, number of exercises, and duration of exercise alongside key data points healthcare providers use to make recommendations about insulin and other medication changes. The data displayed will automatically adjust to reflect the selected date range with visualizations changing based on the type of data.

Syncing Lifestyle Management Data with Glooko

Glooko also supports blood pressure and weight data from compatible blood pressure cuffs and scales from Withings. Bluetooth- and cloud-enabled devices automatically sync with Glooko while readings from non-Bluetooth devices must be manually entered in the Glooko Mobile App to be viewed alongside other health data.

Unlock Deeper Insights by Sharing Health Data with Care Teams

To share data from compatible fitness and health monitoring devices and apps with care teams or use it as a reference, simply ensure the ProConnect Code used by the healthcare team is added. To do this, select “Care Teams” from the home screen, then “+ Care Team,” and enter the designated ProConnect Code using all lowercase letters.

From the Glooko Mobile App home screen, select “Sync Device” then “Add New Device,” which will prompt the user to select a category of devices to add. On this screen, select “Fitness and Health Devices” to search for compatible devices or apps to connect.

Once the data is synced, it will be shared with the user’s healthcare provider remotely and at the next appointment alongside blood sugar, insulin, and other diabetes data. The healthcare provider will have the advantage of seeing how exercise may be impacting glucose levels and will be better prepared for conversations about any insulin dosing adjustments that should be considered.

Time to Upload Exercise and Lifestyle Management Data to Glooko

Visit our Support Center for help with syncing fitness and health monitoring devices and apps with Glooko.

*Not all product features are available in all countries.

Today marks an important milestone in our mission to transform diabetes care. I am excited to share that Glooko has acquired Monarch Medical Technologies, creators of the EndoTool® Glucose Management System.

With this acquisition, Glooko is positioned to become the only diabetes management company with the potential to connect the full continuum of care — from home to hospital and back again. By bringing together EndoTool’s proven inpatient insulin dosing technology with Glooko’s leading outpatient platform, we aim to create a future where care is seamless, safer, and more supportive for both people living with diabetes and healthcare providers.

For patients, this means fewer disruptions as they move between settings, reduced risk of dangerous glycemic events, and more confidence that their care is connected. For healthcare providers, it means access to tools that simplify complex insulin management, standardize protocols, and free up time to focus on what matters most, which is caring for people.

This step also sets the foundation for Glooko’s future: using data and AI to help clinicians anticipate risks earlier, personalize care at scale, and improve outcomes under value-based models. By aligning advanced technology with clinical guidelines and EHR workflows, we can help hospitals and health systems deliver higher-quality care while lowering costs.

Our mission has always been clear: to simplify diabetes management, strengthen connections across the care team, and improve lives. This acquisition represents an important stride toward that vision.

Together, we are building a future where diabetes care is more connected, proactive, and patient-centered than ever.

We’re excited to announce the latest updates to Glooko Web 25.2 and Mobile 6.12, which are designed to help healthcare providers and people with diabetes by streamlining workflows, providing a new population management dashboard to triage at-risk patients and review population-level metrics, improving data visualizations, and giving care teams more powerful data from compatible devices to enhance diabetes management.

Introducing the New Clinic Dashboard

In this release, we launched a new clinic dashboard in the U.S. designed to give healthcare professionals at-a-glance insights into population health trends and clinic management metrics. This enhancement makes it easier to interpret complex data and guide decisions and clinic strategy more efficiently across care teams.

Other new clinic dashboard highlights include:

Population Metrics: This section gives a single, concise, and organized view of the clinic’s total patient population, patients monitoring blood glucose, and those with activated accounts using key engagement and monitoring metrics.
CGM Patient Risk Stratification: This dashboard, modeled after the Timely Interventions for Diabetes Excellence (TIDE) Dashboard, gives healthcare providers a streamlined view of their patient population, ranked by risk level using key glucose metrics and CGM data only. Care teams can identify risk levels using Time in Range, Time Below Range, and other key CGM indicators to prioritize care.
Engagement Metrics: This section helps healthcare providers spot engagement gaps within their patient population over the past 90 days and take action to get more patients connected and syncing their devices with Glooko. With more synced health data, care teams can make more informed treatment decisions.

Banner Notification for Missing MRN

Glooko’s connected care platform prioritizes deep EHR integration to bring actionable diabetes data into the systems clinicians already use. To help maintain EHR data integrity and ensure patient matching is seamless, Glooko introduced a clear dismissible banner on the patient dashboard to notify clinicians when a Medical Record Number (MRN) is required but missing.

Tandem Basal Profile Switches

A new icon in DayView and WeekView on the Glooko diabetes management platform identifies when a patient changes their Tandem Personal Profile to give better context for insulin delivery.

GLP-1 Dose Enhancements

GLP-1 doses will now be displayed in the Glooko Web and Mobile software with improved messaging and clinical disclaimers. Healthcare professionals will now receive relevant dose range notifications while also providing precise dose information to support better oversight and patient adherence, while patients will see exact GLP-1 doses up to two decimal places as injected.

Device Type Display in PDFs

Glooko will now display controller device types in the PDF Settings Report, helping clinicians more clearly understand where data originated for users of Omnipod® 5 and other select devices. The report will specifically say on a clear device label the upload method (e.g., Android, iOS, Locked Down Controller) used by the patient.

Updated Insulin Statistics Design

The Glooko Mobile App’s insulin card has been redesigned to enhance clarity and consistency, particularly benefiting users with insulin pump data. This update aims to improve the understanding of insulin averages and minimize confusion between pump and total insulin values by displaying data in one unified insulin card.

More Information on the Latest Glooko Release

For more detailed information about these new features intended to enhance clinical practices and transform diabetes, be sure to check the full release notes on our Glooko Support page.

The NHS’s ambitious “Fit for the Future: 10 Year Health Plan for England” outlines a bold vision for the future of healthcare in the country — one that is digitally advanced, community-focused, and prevention-driven. It’s a plan designed to move healthcare from a reactive, hospital-centric model to a proactive, patient-empowering system utilising cutting-edge technologies. Within this transformative agenda, Glooko’s diabetes management platform stands out as an excellent example of how digital health solutions can directly support these crucial goals.

From Analogue to Digital: Empowering Patients and Streamlining Care

At the heart of the NHS’s plan is a commitment to becoming “digital by default.” This means harnessing technology to make healthcare more accessible, efficient, and patient-friendly.

Imagine a world where your health data, whether from your BGM, CGM, insulin pen, or activity tracker, is all in one place. That’s what Glooko offers through its integrations with more than 200 diabetes and health monitoring devices, including wearables, a future standard in the NHS by 2035. By centralising this vital information, it empowers people living with diabetes to take a more active role in managing their diabetes and saves them time by not having to juggle multiple apps or manually record readings.

For healthcare professionals, Glooko centralises health data from their patients into a single platform, helping create the “single, secure and authoritative account of their data” that the NHS aims for. To help reduce time-wasting administrative tasks, streamline workflows, and allow clinicians to have more efficient appointments focused on providing quality care, Glooko is expanding its capability to sync with electronic health record (EHR) systems across England and the rest of Europe. When all the relevant data is at their fingertips and seamlessly flowing between clinical records and the Glooko platform, everyone on the care team, including diabetologists, diabetes specialist nurses, registered dietitians, and general practitioners, can make more informed clinical decisions using our diabetes technology.

With our commitment to safeguarding confidential personal information and handling patient data properly, our diabetes management platform and our company’s practices meet the NHS’s data security standards outlined in the Data Security and Protection Toolkit. We align with the NHS’s requirements for all organisations with access to their patient data and systems.

From Hospital to Community: Enabling Remote Monitoring and Personalised Care

The NHS plan emphasises shifting care away from hospitals and into local communities and even patients’ homes. Glooko is instrumental in making this a reality for diabetes care with its remote patient monitoring capabilities.

This innovative feature of our diabetes software for healthcare providers means fewer trips to the hospital for routine check-ups and more proactive management of diabetes from the comfort of a patient’s home. This not only improves convenience for people living with diabetes but also helps to alleviate pressure on acute hospital services and supports the development of community-based models like “Neighbourhood Health Centres.”

The Glooko connected care platform offers powerful population health analytics. This allows hospitals to view trends and manage their entire patient population more effectively, aligning with the NHS’s goal of preventing illness and managing long-term conditions on a larger scale. The detailed insights provided by Glooko’s data can also support the creation and monitoring of highly personalised care plans, moving closer to the NHS’s goal of offering personal health budgets and tailored support for complex needs like diabetes.

From Sickness to Prevention: Proactive Management and Improved Outcomes

A core tenet of the NHS’s 10 Year Health Plan is a strong focus on prevention and early intervention.

By providing continuous diabetes and related health data and insights, Glooko helps healthcare providers identify potential issues and risks before they escalate. This allows for proactive intervention, which can significantly reduce the likelihood of diabetes-related complications, improving long-term health for patients.

And Glooko isn’t just about data; it’s about demonstrable results. The diabetes management platform has a track record of improving clinical outcomes, including reduced HbA1c levels. These outcomes directly align with the NHS’s aspirations for better health for the population, reduced demand on acute services, and a more sustainable healthcare system.

A Healthier Future for People with Diabetes

We want the NHS 10 Year Health Plan to deliver real improvements for people with diabetes and their care teams. Glooko is more than a diabetes management tool; we’re a strategic partner committed to helping the NHS deliver better care for all patients regardless of wherever they live and whatever they earn.

By accelerating digital transformation, enabling care at home, and championing proactive diabetes management, Glooko is helping build a more efficient, patient-centered, and digitally advanced healthcare system.

With innovative solutions and preferred vendors like Glooko, the NHS is well-equipped to meet the challenges and opportunities ahead as they usher in the future of healthcare in England.

Managing diabetes care has become increasingly complex for clinics, hospitals, and health systems. With a growing number of people living with diabetes relying on multiple devices — glucose meters, continuous glucose monitors (CGMs), insulin pumps, and wearables — healthcare providers face the challenge of piecing together critical data from siloed systems. This fragmentation not only consumes valuable time, but hinders patient care.

At Glooko, we know device integration is the key to solving these challenges and transforming diabetes management. As a market leader in device compatibility, EHR integration, and interoperability, Glooko increases efficiency of clinical workflows by streamlining administrative tasks, enhances patient engagement, and helps deliver better outcomes.

The Challenges of Fragmented Diabetes Management

For healthcare providers, piecing together data from various devices and platforms and apps can feel like an endless puzzle. Without device integrations, clinics and health systems face:

Disconnected Data: Patient data is scattered across incompatible platforms and apps, making it difficult to understand a patient’s holistic health.
Inefficient Workflows: Healthcare providers must spend time manually entering or retrieving data instead of focusing their time and expertise to support their patients in achieving better health.
Limited Patient Engagement: Patients often struggle to track their progress with so many different tools and apps, becoming overwhelmed and losing hope in their ability to make meaningful change.

These challenges contribute to missed opportunities for timely interventions that drive better health outcomes.

How Glooko’s Compatibility Brings Clarity to Diabetes Care

Glooko simplifies diabetes management by integrating data from more than 200 diabetes and health monitoring devices — including Abbott’s FreeStyle Libre CGMs in the U.S. — into a single, user-friendly platform.

Here’s how Glooko’s device compatibility transforms care:

Data Integration and Interoperability: Glooko consolidates glucose levels, insulin usage, and lifestyle behaviors such as diet and physical activity, giving healthcare providers a holistic view of patient health. Care teams can easily access patient data from a centralized platform.
Remote Monitoring Capabilities: Healthcare providers can track patient trends and progress between visits, ensuring timely adjustments to care plans and reducing unnecessary appointments and emergency room visits.

Not all devices are available in every country where Glooko is available. The product images are for illustrative purposes only. Not actual patient data. The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott and used with permission. Important Safety Information: For full FreeStyle Libre systems safety information, please visit https://www.freestyle.abbott/us-en/safety-information.html.

The Many Benefits of Integration for Clinics, Hospitals, and Health Systems

Our industry-leading device compatibility benefits clinics, hospitals, and health systems by streamlining workflows and improving decision-making through a comprehensive view of patient data. With greater efficiency, care teams can focus more on patient care and expand their reach to serve more individuals in need.

Streamlined Workflows: Staff spend less time on administrative tasks and more time on what they do best: educating and providing care to their patients.
Improved Decision-Making: A comprehensive view of patient data allows care teams to create more personalized and effective treatment plans.
Expanded Clinical Footprint: With more time, clinicians can help more patients in need.

To enable more meaningful data insights, Glooko also seamlessly integrates the health data from their patients’ diabetes and health monitoring devices directly into leading EHR systems, eliminating manual uploads and platform switching and reducing administrative burden.

The Key Benefits of Device Integrations for People Living with Diabetes

Glooko’s device integrations benefit people living with diabetes by simplifying their experience and empowering self-management through centralized data, reducing app overload and supporting informed health decisions.

Simplified Experience: With integrated data, patients no longer need to juggle multiple apps and passwords, or manually report their glucose levels to their provider.
Empowered Self-Management: Patients can log meals, exercise, and medications directly in the Glooko app, helping them understand how their choices impact their health.

Proven Results Backed by Global Expertise

Glooko has more than a decade of experience integrating diabetes and health monitoring devices worldwide, supporting millions of people living with diabetes. Glooko’s connected care platform, backed by real-world evidence, delivers the reliability, scalability, and insights clinics, hospitals, and health systems need to stay ahead in diabetes care, setting a new standard.

Simplify Diabetes Care with Glooko

The complexity of diabetes management doesn’t have to hold your clinic, hospital, or health system back. By choosing Glooko, you can eliminate data fragmentation, enhance patient care, and create a more efficient, streamlined experience for healthcare providers and people living with diabetes.

Schedule a personalized demo of our digital health platform today and see how your patients’ health data can be integrated directly into your EHR system.

As a leader in diabetes management, Glooko offers an intelligent connected care platform that allow people with diabetes and their healthcare providers to review, analyze, and evaluate data from many different types of diabetes devices, including blood glucose meters (BGM), continuous glucose monitoring (CGM) systems, insulin pumps, smart pens, and fitness apps.

With Glooko’s digital health solution allowing users to view and analyze CGM and insulin data in one place, we have the ability to work with hybrid closed loop systems, a technology — often known as an artificial pancreas — that automates many of the daily decisions of people living with Type 1 diabetes who use an insulin pump and CGM that communicate with each other.

Innovative hybrid closed loop systems take readings from an individual’s CGM and use an algorithm to automatically tell the insulin pump how much insulin to deliver to keep blood glucose levels stable around the clock.

How Glooko integrates with hybrid closed loop systems

Our digital health platform, used by over 10,000 clinics in more than 30 countries, syncs via the cloud with leading diabetes CGMs and insulin pumps in hybrid closed loop systems to automatically present data around glucose levels, basal rates and more to patients and their care teams via graphically-oriented reports that can help recognize trends, so they can take action to improve their health outcomes.

The hybrid closed loop systems that currently sync with Glooko include:

Depending on the brands of the insulin pump and CGM, different methods of syncing via cloud are required to view data in Glooko from hybrid closed loop systems.

Glooko and Hybrid Closed Loop Systems for Diabetes — **Method 1**

Like any great technology, people living with diabetes using a closed loop system still must check to ensure it is working and must count carbohydrates to give the system the correct bolusing data before food consumption. This is where the Glooko Mobile App’s food tracker can be used to track nutrition by searching the food database, using voice capture, or scanning a barcode (in select countries).

Benefits of using hybrid closed loop systems with Glooko

There are many benefits of using hybrid closed loop systems alongside Glooko for patients, including:

Major changes in treatment that reduce daily burdens and mental stress
More time with glucose levels in range with less effort
The ability to visualize blood glucose and insulin data in clear graphs that make it easier to understand automatic boluses and basal rates

There are also many benefits of using hybrid closed loop systems alongside Glooko for care teams, including:

An increased monitoring of patients with diabetes who are using closed loop systems
Strengthening their connection with their patients
Better management of fluctuations in patients’ glucose levels
Easier interpretation of patient data around basal rate, automatic vs. manual mode and automatic boluses

The future of hybrid closed loop systems

Hybrid closed loop systems in diabetes care are advancing toward more automation, intelligence, and accessibility. These systems are on a path toward becoming fully closed loop systems that will make managing diabetes more automated, adaptive, and accessible, allowing users to focus less on their condition and more on living life.

As the systems evolve, so will Glooko. With the regular introduction of new hybrid closed loop systems, Glooko will continue to partner with leading device manufacturers to integrate their platforms with our digital health solution.

For more information about using a hybrid closed loop system, consult with your healthcare team and explore resources from the Breakthrough T1D, Diabetes UK, and NHS England.